Featured Articles

The Influence of Dermatologists’ Use of Social Media on Attracting Patients

By April 29, 2020No Comments

JDD Multimedia

Featured Article

Emily C. Murphy BS, Kamaria Nelson MD, and Adam J. Friedman MD

In a new article, published in the May 2020 issue of the JDD,  “The Influence of Dermatologists’ Use of Social Media on Attracting Patients,” authors Emily C. Murphy BS,a,b Kamaria Nelson MD,a and Adam J. Friedman MDa examine how social media influences patients when choosing a dermatologist and the aspects of dermatologists’ sites that offer the most benefits to patients.

Read Article Now

"The Influence of Dermatologists’ Use of Social Media on Attracting Patients"

As of 2019, 79% of Americans have a social media profile, with the majority using platforms such as Facebook, Twitter, YouTube, and Instagram.1 Social media was originally created to connect with family and friends, but individuals now use it to self-promote, to disseminate information, and for activism.

Physicians are even more likely to use social media than the general population, with 87% having an account in 2011.2 In the medical community, social media allows for the distribution of health information and may increase healthcare access by connecting patients and physicians.3,4 Despite these benefits, there is also concern among practitioners about the misuse of social media given its lack of regulation, which may lead to inappropriate online consultations, spread of false information, and HIPAA violations.3

In a new article, published in the May 2020 issue of the JDD,  “The Influence of Dermatologists’ Use of Social Media on Attracting Patients,” authors Emily C. Murphy BS,a,b Kamaria Nelson MD,a and Adam J. Friedman MDa examine how social media influences patients when choosing a dermatologist and the aspects of dermatologists’ sites that offer the most benefits to patients.

Read Article Now

You May Also Like

Featured ArticlesLatest NewsRosaceaClascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial
September 4, 2026

Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial

Investigating Clascoterone Cream 1% for Papulopustular Rosacea: Key Takeaways  This is a must-read article from JDD for clinicians seeking fresh therapeutic avenues for chronic facial dermatoses. Managing papulopustular rosacea often…
Journal of Drugs in Dermatology JDD featuring Optimizing Melasma Management With Topical Tranexamic Acid: An Expert ConsensusDyspigmentationFeatured ArticlesLatest NewsOptimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus
September 4, 2026

Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus

From the Vault: Managing Recurrent Hyperpigmentation Beyond Standard Hydroquinone Regimens Given its complex pathogenesis, chronicity, and high rates of recurrence, melasma remains one of the most challenging conditions in aesthetic…
Featured ArticlesFeatured PodcastLatest NewsPodcastPodcast HighlightsShots, Shots, Shots: Is There Such a Thing as One Too Many?
September 4, 2026

Shots, Shots, Shots: Is There Such a Thing as One Too Many?

Guest: Dr. Joseph Bax Corticosteroid injections are everywhere in musculoskeletal medicine. Epidurals, joints, facets, bursae: when inflammation and pain are the targets, steroids have long been one of the sharpest…

Leave a Reply